CCND1 and ovarian carcinoma: Our data showed that induction of apoptosis and cell cycle G1 arrest are key components of the anti-tumorigenic effects of NT1014 in ovarian cancer cells, as evidenced by induced expression of annexin V, p27, and p21 as well as reduction of BCL, Mcl-1, cyclin D1, and CDK expression.